Clinical Trials on Hormone Receptor-positive Breast Cancer in Singapore

Total 226 results

National Cancer Centre, Singapore
MSD Pharma (Singapore) Pte Ltd

Recruiting

Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole (LaPemERLA)

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Singapore
Novartis Pharmaceuticals

Completed

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Japan, Hong Kong, Singapore
National University Hospital, Singapore
National Cancer Centre, Singapore

Unknown

Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer

ErbB2-Positive Stage I-III Breast Cancer

Singapore
Hoffmann-La Roche

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

United States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
Genentech, Inc.

Recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer

Korea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
National University Hospital, Singapore

Recruiting

Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)

Advanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast Cancers

Singapore
National Cancer Centre, Singapore
Singapore General Hospital; Singapore Cancer Society; Genome Institute of Singapore and other collaborators

Recruiting

Breast Cancer Exercise Intervention Study (BREXINT)

Locally Advanced Breast Cancer | Early-stage Breast Cancer

Singapore
National University, Singapore
Singapore General Hospital; National Cancer Centre, Singapore

Recruiting

A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors

Breast Cancer Female

Singapore
KK Women's and Children's Hospital

Unknown

A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .

Breast Cancer Female

Singapore
National University Hospital, Singapore

Completed

Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer

Metastatic Breast Cancer

Singapore
National University Hospital, Singapore

Completed

Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer

Early Breast Cancer

Singapore
National University Hospital, Singapore

Completed

Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer

Metastatic Breast Cancer

Singapore
MiRXES Pte Ltd

Recruiting

Project CADENCE (CAncer Detected Early caN be CurEd) (CADENCE)

Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver Cancer

Singapore
HE Hong-Gu
KK Women's and Children's Hospital; Buddy Healthcare Ltd OY

Unknown

An Innovative Care-improvement Smartphone-based Perioperative Solution for Women Undergoing Breast Cancer Surgery (iCareBreast)

Surgery | Breast Cancer Female

Singapore
Novartis Pharmaceuticals

Completed

Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab

Advanced HER2-positive Breast Cancer

France, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
National University Hospital, Singapore
Merck Sharp & Dohme LLC; Adagene Inc

Recruiting

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer (ComPACT)

Triple Negative Breast Cancer | Advanced Solid Tumor

Singapore
National University Hospital, Singapore

Completed

Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer

Metastatic Breast Cancer

Singapore
National University Hospital, Singapore
Adagene Inc

Recruiting

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

Advanced Solid Tumor | HER2-negative Breast Cancer

Singapore
National University, Singapore
National Cancer Centre, Singapore

Unknown

Accessible Cancer Care to Enable Support for Survivors Programme (ACCESS)

Breast Cancer | Gynecologic Cancer | Survivorship

Singapore
National University of Singapore
National University Hospital, Singapore; National Cancer Centre, Singapore

Completed

Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors

Quality of Life | Oncology | Breast Cancer Survivors | Symptom Management | Mindfulness Based Cognitive Therapy

Singapore
National University Hospital, Singapore
National University of Singapore

Recruiting

Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)

Breast Cancer

Singapore
National University Hospital, Singapore
Eisai Co., Ltd.

Unknown

Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer

Breast Cancer

Singapore
National Cancer Centre, Singapore

Completed

Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Study of Circulating and Tumor Biomarkers in Breast Cancer Patients

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Using National University Cancer Institute of Singapore (NCIS) Registry to Measure Time Trends in Quality of Care for Breast Cancer Patients in a National Cancer Centre

Breast Cancer

Singapore
National Cancer Centre, Singapore

Terminated

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Singapore
National University Hospital, Singapore

Completed

Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer

Breast Cancer

Singapore
National University Hospital, Singapore

Recruiting

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

Breast Cancer

Singapore
National University Hospital, Singapore
Eisai Co., Ltd.; Tan Tock Seng Hospital

Unknown

Phase II Study of Single Agent Lenvatinib

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Development of Predictive Biomarkers and Novel Approached to Therapy in Breast Cancer

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Uncovering Potential Breast Cancer Biomarkers Amp; Possible Drug Targets Using Advanced Quantitative Mass Spectrometry

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Knowledge and Attitudes of Patients and Healthcare Professionals on a Spectrum of Genetic Tests Relevant to Breast Cancer Patients

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

A Prospective Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive Function of Breast Cancer Patients

Breast Cancer

Singapore
National Cancer Centre, Singapore

Unknown

Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Singapore
National University Hospital, Singapore

Recruiting

Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer (QUEST)

Breast Cancer

Singapore
Changi General Hospital

Completed

Surgical and Patient Reported Outcomes in Robotic Mastectomy

Breast Cancer

Singapore
National Cancer Centre, Singapore
National Medical Research Council (NMRC), Singapore

Active, not recruiting

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Breast Cancer

Singapore
National University Hospital, Singapore
Singapore Cancer Society

Completed

Multidisciplinary Rehabilitation Programme for Breast Cancer

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

A Prospective Study on Effect of Systemic Adjuvant Therapy on Cognitive and Brain Function of Breast Cancer Patients

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Metformin and Simvastatin in Addition to Fulvestrant

Breast Cancer

Singapore
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Correlation Between Genetic Variants and Long-term Cardiac Effects Induced by Doxorubicin in Breast Cancer Patients

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Breast Cancer Registry - National University Health System, Singapore

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient

Breast Cancer

Singapore
National Cancer Centre, Singapore
SingHealth Polyclinics; National University of Singapore

Completed

Impact of a Breast cAncer Survivorship Interprofessional Community Care Model (BASIC)

Breast Cancer | Survivorship

Singapore
Duke-NUS Graduate Medical School

Recruiting

Marital Satisfaction and Sexual Health of Female Cancer Patients in Singapore (RISE)

Breast Cancer | Gynecologic Cancer

Singapore

3

Subscribe